Share this article
Share this article
NEW YORK, April 15, 2021 /PRNewswire/ Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the B. Riley Securities Neuroscience Conference, April 28-29, 2021.
Raj Mehra, Ph.D., Chairman and CEO, will present on Wednesday, April 28th at 11:00am ET.
The B. Riley Securities Neuroscience Conference will cover key topics across neurodegeneration, neuropsychiatry, and mental health disease areas, with both public and private healthcare companies. For more information about the conference: https://brileyfin.com/events
Prioritise the psychological needs of children ghanaiantimes.com.gh - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ghanaiantimes.com.gh Daily Mail and Mail on Sunday newspapers.
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Hansa Biopharma to host conference call to provide interim results from Q1 2021 and Business Update
News provided by
Share this article
Share this article
LUND, Sweden, April 14, 2021 /PRNewswire/ Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-March 2021 at 8:00 CET on April 22, 2021. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 14:00 CET/8:00am EST. The event will be hosted by Hansa Biopharma s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English.
Share:
20.7 million tonnes of CO2 emissions potentially saved by online consumers
London and Oslo, 14 April 2021: 20.7 million tonnes of carbon dioxide emissions were potentially saved by consumers who chose to buy and sell used items through ten online marketplaces operated by Adevinta and Schibsted, according to the Second Hand Effect 2020 report (SHE), published today. By offering users platforms where they can buy and sell, online marketplaces reduce the need for newly produced goods and promote more sustainable consumption. This key concept is what Adevinta and Schibsted call the Second Hand Effect. The report, the methodology for which was developed in close collaboration with IVL, the Swedish Environmental Research Institute and sustainability consultancy Ethos International, is in its eighth iteration since launching in 2013. It looks at how much CO2 and materials (plastic, steel and aluminium) have potentially been saved through second-hand trade on participating ma